BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 27639681)

  • 1. Dextran-poly lactide-co-glycolide polymersomes decorated with folate-antennae for targeted delivery of docetaxel to breast adenocarcinima in vitro and in vivo.
    Alibolandi M; Abnous K; Hadizadeh F; Taghdisi SM; Alabdollah F; Mohammadi M; Nassirli H; Ramezani M
    J Control Release; 2016 Nov; 241():45-56. PubMed ID: 27639681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
    Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
    Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
    Jiang S; Gong X; Zhao X; Zu Y
    Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
    El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
    Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate.
    Esmaeili F; Ghahremani MH; Ostad SN; Atyabi F; Seyedabadi M; Malekshahi MR; Amini M; Dinarvand R
    J Drug Target; 2008 Jun; 16(5):415-23. PubMed ID: 18569286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.
    Cai X; Yang X; Wang F; Zhang C; Sun D; Zhai G
    J Biomed Nanotechnol; 2016 Jul; 12(7):1453-62. PubMed ID: 29337470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
    Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
    Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells.
    Patel J; Amrutiya J; Bhatt P; Javia A; Jain M; Misra A
    J Microencapsul; 2018 Mar; 35(2):204-217. PubMed ID: 29542378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
    Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.
    Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L
    Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
    Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
    Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted folate-conjugated pluronic P85/poly(lactide-co-glycolide) polymersome for the oral delivery of insulin.
    Xie S; Gong YC; Xiong XY; Li ZL; Luo YY; Li YP
    Nanomedicine (Lond); 2018 Oct; 13(19):2527-2544. PubMed ID: 30338724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation.
    Alibolandi M; Alabdollah F; Sadeghi F; Mohammadi M; Abnous K; Ramezani M; Hadizadeh F
    J Control Release; 2016 Apr; 227():58-70. PubMed ID: 26907831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
    Senthilkumar M; Mishra P; Jain NK
    J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.